
Megacilin(4 gm+0.5
Popular Pharmaceuticals Ltd.
Piperacillin + Tazobactam is an injectable combination antibiotic (an extended-spectrum penicillin plus a beta-lactamase inhibitor) used to treat serious bacterial infections caused by susceptible and more.
Piperacillin + Tazobactam is an injectable combination antibiotic (an extended-spectrum penicillin plus a beta-lactamase inhibitor) used to treat serious bacterial infections caused by susceptible, including beta-lactamase-producing, organisms.
The final choice of antibiotic and duration of therapy should be guided by culture and sensitivity results and a physician's clinical judgment.
Piperacillin + Tazobactam is given only by intravenous infusion, usually over 30 minutes (extended infusions of 3–4 hours may be used in some hospital protocols for severe infections, per local practice). Dose and frequency depend on the indication, severity of infection, and renal function.
| Indication (adults) | Typical adult dose |
|---|---|
| Intra-abdominal / skin-structure infections | 3.375 g IV every 6 hours |
| Nosocomial pneumonia | 4.5 g IV every 6 hours (with an aminoglycoside), usually for 7–14 days |
| Febrile neutropenia (empiric) | 4.5 g IV every 6 hours, usually with an aminoglycoside |
Dose and/or frequency must be reduced according to creatinine clearance (CrCl), as advised by the treating physician; patients on hemodialysis require an additional dose after each dialysis session.
Take exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. Completing the full prescribed course helps prevent treatment failure and antibiotic resistance.
Most people tolerate Piperacillin + Tazobactam well, but side effects can occur.
Seek prompt medical attention for severe rash, difficulty breathing, swelling of the face/throat, severe or persistent diarrhea, or unusual bleeding/bruising.
Piperacillin + Tazobactam is contraindicated in patients with a known history of hypersensitivity (including anaphylaxis) to piperacillin, tazobactam, any penicillin, or any beta-lactamase inhibitor. Because of cross-reactivity within the beta-lactam class, Piperacillin + Tazobactam should also not be given to patients with a documented history of severe immediate hypersensitivity (e.g. anaphylaxis) to cephalosporins or other beta-lactam antibiotics.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.